Combining data tokenization and real-world patient insights to bridge the gap for a more diverse and complete dataset
Clinical expert, David Barrett shares insights on how we linked real-world data with personal characteristics, such as race, ethnicity, and social determinants of health, to gain a more complete view of patients. This research aims to educate drug developers on ways to improve patient representation in clinical trials, address shortcomings in linking real-world data (RWD), and enhance the understanding of patient journeys and outcomes.
Clinical research using real-world data (RWD) typically faces shortcomings in linking that data with a patient’s personal characteristics and experience, clouding the researchers’ view of the individual patient.
To address this, Parexel initiated a study protocol that aimed to evaluate technologies for linking participant engagement with RWD to try to close this gap. With this initiative, we incorporated innovative data science techniques using streamlined technology integration and tokenization. Our goal was to demonstrate that we could develop a more complete and holistic view of an individual patient through this methodology.
Download to see what we found.
Related Insights
Blog
Studying rare cancer patient populations using integrated genomic and real-world data
Aug 30, 2023
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Webinar
Investor-ready strategy: Integrated evidence planning to maximize commercial opportunity
Sep 17, 2025
Blog
Patient Advocacy Groups: A vital partner for sponsors that understand how to engage with patients
May 3, 2022
Blog
Including patients in DCT design
Sep 13, 2022
Blog
Taking a Proactive Approach to Post-Launch Patient Accessibility in Strategic Planning
Aug 4, 2022
Video
A Life in a Day
Jul 28, 2022
Video
Parexel Site Alliances
Jul 13, 2022
Video
Nurse Advisory Panel
Jul 13, 2022
Blog
Parexel names first Patient Ambassador
Jun 17, 2022
Blog
Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions
May 16, 2022
Article
New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle
May 10, 2022
Related Insights
Blog
Studying rare cancer patient populations using integrated genomic and real-world data
Aug 30, 2023
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Webinar
Investor-ready strategy: Integrated evidence planning to maximize commercial opportunity
Sep 17, 2025
Blog
Patient Advocacy Groups: A vital partner for sponsors that understand how to engage with patients
May 3, 2022
Blog
Including patients in DCT design
Sep 13, 2022
Blog
Taking a Proactive Approach to Post-Launch Patient Accessibility in Strategic Planning
Aug 4, 2022
Video
A Life in a Day
Jul 28, 2022
Video
Parexel Site Alliances
Jul 13, 2022
Video
Nurse Advisory Panel
Jul 13, 2022
Blog
Parexel names first Patient Ambassador
Jun 17, 2022
Blog
Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions
May 16, 2022
Article
New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle
May 10, 2022